Total Payments
$597.97
2024 Payments
$47.09
Companies
13
Transactions
25
Medicare Patients
425
Medicare Billing
$42,825
Payment Breakdown by Category
Food & Beverage$523.98 (87.6%)
Education$73.99 (12.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $523.98 | 24 | 87.6% |
| Education | $73.99 | 1 | 12.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $124.81 | 4 | $0 (2022) |
| Incyte Corporation | $119.10 | 3 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $98.10 | 5 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $53.77 | 3 | $0 (2021) |
| ABBVIE INC. | $47.49 | 2 | $0 (2024) |
| Lilly USA, LLC | $25.88 | 1 | $0 (2021) |
| Pharmacyclics LLC, an AbbVie Company | $25.76 | 1 | $0 (2022) |
| Coherus Biosciences Inc. | $24.74 | 1 | $0 (2021) |
| Amgen Inc. | $24.49 | 1 | $0 (2021) |
| Dendreon Pharmaceuticals LLC | $23.60 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $47.09 | 2 | ABBVIE INC. ($26.59) |
| 2023 | $36.36 | 2 | ABBVIE INC. ($20.90) |
| 2022 | $85.28 | 3 | Janssen Pharmaceuticals, Inc ($43.35) |
| 2021 | $429.24 | 18 | Incyte Corporation ($119.10) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/02/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $26.59 | General |
| Category: ONCOLOGY | ||||||
| 01/30/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Oncology | ||||||
| 07/21/2023 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: ONCOLOGY | ||||||
| 02/21/2023 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug), SCEMBLIX | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Oncology | ||||||
| 10/04/2022 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), SCEMBLIX, TASIGNA | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: ONCOLOGY | ||||||
| 07/07/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $43.35 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/09/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: ONCOLOGY | ||||||
| 12/15/2021 | Incyte Corporation | JAKAFI (Drug), PEMAZYRE | Food and Beverage | Cash or cash equivalent | $25.93 | General |
| Category: Hematology/Oncology | ||||||
| 12/13/2021 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: Oncology | ||||||
| 11/29/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $32.97 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/22/2021 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $16.35 | General |
| 11/04/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2021 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 10/27/2021 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: ONCOLOGY | ||||||
| 10/26/2021 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: Oncology | ||||||
| 10/19/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/10/2021 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/30/2021 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Oncology | ||||||
| 09/22/2021 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $19.18 | General |
| Category: Hematology/Oncology | ||||||
| 09/22/2021 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $4.42 | General |
| Category: Oncology | ||||||
| 09/08/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: ONCOLOGY | ||||||
| 08/17/2021 | Incyte Corporation | — | Education | Cash or cash equivalent | $73.99 | General |
| 07/08/2021 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: ONCOLOGY | ||||||
| 05/07/2021 | Genentech USA, Inc. | Kadcyla (Biological), TECENTRIQ, Phesgo | Food and Beverage | In-kind items and services | $8.43 | General |
| Category: BioOncology | ||||||
| 04/21/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 57 | 61 | $18,945 | $5,965 |
| 2021 | 7 | 368 | 896 | $102,972 | $36,861 |
Total Patients
425
Total Services
957
Medicare Billing
$42,825
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 34 | 35 | $15,365 | $4,917 | 32.0% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 11 | 12 | $2,376 | $659.08 | 27.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 12 | 14 | $1,204 | $388.08 | 32.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 181 | 307 | $48,199 | $19,663 | 40.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 46 | 120 | $27,480 | $11,146 | 40.6% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 14 | 15 | $5,700 | $1,615 | 28.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 20 | 28 | $5,628 | $1,493 | 26.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 28 | 139 | $7,645 | $1,468 | 19.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 31 | 129 | $5,160 | $1,002 | 19.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 48 | 158 | $3,160 | $474.00 | 15.0% |
About Emma Servatius
Emma Servatius is a Nurse Practitioner healthcare provider based in Lisle, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/01/2021. The National Provider Identifier (NPI) number assigned to this provider is 1043801020.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Emma Servatius has received a total of $597.97 in payments from pharmaceutical and medical device companies, with $47.09 received in 2024. These payments were reported across 25 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($523.98).
As a Medicare-enrolled provider, Servatius has provided services to 425 Medicare beneficiaries, totaling 957 services with total Medicare billing of $42,825. Data is available for 2 years (2021–2022), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Lisle, IL
- Active Since 02/01/2021
- Last Updated 03/06/2021
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1043801020
Products in Payments
- XARELTO (Drug) $124.81
- VENCLEXTA (Drug) $47.49
- JAKAFI (Drug) $45.11
- PROMACTA (Drug) $40.26
- KEYTRUDA (Biological) $37.42
- VERZENIO (Drug) $25.88
- IMBRUVICA (Drug) $25.76
- Udenyca (Biological) $24.74
- LUMAKRAS (Drug) $24.49
- PROVENGE (Drug) $23.60
- MEKINIST (Drug) $21.88
- SCEMBLIX (Drug) $20.50
- ERLEADA (Drug) $17.38
- TASIGNA (Drug) $15.46
- Kadcyla (Biological) $8.43
- Rubraca (Drug) $4.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Lisle
Mrs. Jennifer Jump, Aprn Fnp-Bc, APRN FNP-BC
Nurse Practitioner — Payments: $4,564
Nurse Practitioner $4,564
Rosaleen Lim, Apn, APN
Nurse Practitioner — Payments: $1,998
Nurse Practitioner $1,998
Mrs. Sheila Erasmus, Np-C, NP-C
Nurse Practitioner — Payments: $1,560
Nurse Practitioner $1,560
Sarah Ramsland, Apn, Cnp, APN, CNP
Nurse Practitioner — Payments: $866.59
Nurse Practitioner $866.59
Jennifer Buening, Apn, Fnp-C, APN, FNP-C
Nurse Practitioner — Payments: $727.75
Nurse Practitioner $727.75
Michael Taccona, Aprn, Fnp-C, APRN, FNP-C
Nurse Practitioner — Payments: $719.30
Nurse Practitioner $719.30